Trial Profile
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of NV-101 in Dental Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs Phentolamine (Primary)
- Indications Numbness; Regional anaesthesia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novalar Pharmaceuticals
- 14 May 2014 New trial record